Clover Health Investments, Corp.
CLOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $0 | $0 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $1 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 8.8% | 15% | -25.5% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 26.6% | 20.3% | 9.4% | -5.4% |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | -3.3% | -16.5% | -23% | -38.7% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -3.1% | -16.9% | -31% | -39.9% |
| EPS Diluted | -0.088 | -0.45 | -0.71 | -1.25 |
| % Growth | 80.5% | 36.6% | 43.2% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |